Bezalip, also known by its generic name bezafibrate, is a medication primarily used in the management of hyperlipidemia, which is a condition characterized by elevated levels of lipids or fats in the blood, including cholesterol and triglycerides. It belongs to the class of drugs known as fibrates, which work by activating peroxisome proliferator-activated receptors (PPARs) in the body. This activation leads to an increase in the breakdown of lipids and a decrease in the production of triglycerides, thereby lowering their levels in the blood. Bezalip is effective in reducing low-density lipoprotein (LDL) cholesterol and triglycerides, and in increasing high-density lipoprotein (HDL) cholesterol, which is often referred to as "good" cholesterol. It is typically prescribed when diet, exercise, and weight loss have not been sufficient to lower lipid levels to a desired range. As with any medication, it is important to use Bezalip under the guidance of a healthcare professional to ensure its safe and effective use.